Proteomics Analysis of Human Tears in the Diagnosis and Management of Dry Eye Disease
Recruiting
N/A
Interventional Study
Dry Eye Disease (DED)
Dry Eye
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 75 (estimated)
- Sponsor
- The Hong Kong Polytechnic University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this study, the initial tear proteome profiles in Dry Eye Disease (DED) patients, the safety and effectiveness of using an EC certificate DED treatment device in DED management, together with the associated global tear proteome changes, will be investigated.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* OSDI score ≥ 13, and
* Fail one of the three diagnostic tests:
* Non-invasive tear break-up time (NITBUT) less than 10s;
* Tears osmolarity higher than or equals to 308 mOsm/L or inter-ocular difference \> 8 mOsm/L;
* When assessing with slit lamp, shows more than 9 spo…
Contacts